Biggest News Aggregation in the World
📰 Hartmutj Ehrlich News

Page 7 - Hartmutj Ehrlich News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Hartmutj Ehrlich. Real-time updates on events, politics, business and more.

Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference

DGAP-News: ABIVAX / Key word(s): Conference15.12.2021 / 18:30 The issuer is solely responsible for the content of this announcement.Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference Abivax's presentation at the virtual J.P. Morgan Healthcare Conference scheduled for Thursday, January 13, 20...
France General United Kingdom San Diego United States University Of California San Diego William Sandborn

Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis

Abivax SA , a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and cancer, today announced that... | December 1, 2021
United States France General Hartmutj Ehrlich European Medicines Agency Drug Administration Euronext Paris

Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulce

DGAP-News: ABIVAX / Key word(s): Study01.12.2021 / 19:30 The issuer is solely responsible for the content of this announcement.Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitisEnd-of-phase-2 response from the US regulatory agency (FDA) provides guidanc...
United States France General Hartmutj Ehrlich Enregistrement Universel European Medicines Agency Drug Administration

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative coli

Search jobs 24-May-2021 Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3 DGAP-News: ABIVAX / Key word(s): Study results 24.05.2021 / 18:30 The issuer is solely responsible for the content of this announcement. Abivax reports excellent efficacy and safety of ABX464 in phase 2b clinical trial in ulcerative colitis and plans to proceed to phase 3 Primary endpoint ...
New York United States France General United Kingdom Region Flamande Pbruce Sands

Abivax Follows DSMB Recommendation to Stop the Phase 2b/3 miR-AGE Covid-19 Clinical Trial Due to Lack of Efficacy

Press release content from Accesswire. The AP news staff was not involved in its creation. Abivax Follows DSMB Recommendation to Stop the Phase 2b/3 miR-AGE Covid-19 Clinical Trial Due to Lack of Efficacy March 5, 2021 GMT The Data Safety and Monitoring Board (DSMB) confirmed ABX464 was safe and well tolerated in 383 high-risk Covid-19 patients Lower than expected rate (10.1%) of progression to severe disease or death with no difference between ABX464 and placebo groups Decision has no impact ...
United States France General Eric Cua Chris Maggos Regina Jehle Enregistrement Universel
Source: apnews.com

Investegate |ABIVAX Announcements | ABIVAX: Abivax follows DSMB recommendation to stop the phase 2b/3 miR-AGE Covid-19 clinical trial due to lack of efficacy

ABIVAX Abivax follows DSMB recommendation to stop the phase 2b/3 miR-AGE Covid-19 clinical trial due to lack of efficacy DGAP-News: ABIVAX / Key word(s): Study Abivax follows DSMB recommendation to stop the phase 2b/3 miR-AGE Covid-19 clinical trial due to lack of efficacy 05.03.2021 / 20:00 Abivax follows DSMB recommendation to stop the phase 2b/3 miR-AGE Covid-19 clinical trial  due to lack of efficacy The Data Safety and Monitoring Board (DSMB) confirmed ABX464 was safe and well tolerate...
France General Eric Cua Hartmutj Ehrlich Jorge Kalil Research National Priority University Hospital Center

Investegate |ABIVAX Announcements | ABIVAX: Abivax publishes data of ABX464 induction and long-term maintenance phase 2a ulcerative colitis study in the prestigious journal 'Gastroenterology'

ABIVAX Abivax publishes data of ABX464 induction and long-term maintenance phase 2a ulcerative colitis study in the prestigious journal Gastroenterology DGAP-News: ABIVAX / Key word(s): Miscellaneous Abivax publishes data of ABX464 induction and long-term maintenance phase 2a ulcerative colitis study in the prestigious journal Gastroenterology 03.03.2021 / 18:30 The issuer is solely responsible for the content of this announcement. Abivax publishes data of ABX464 induction and long-term mainte...
Region Flamande France General Hartmutj Ehrlich University Hospitals Leuven Euronext Paris Investegate Announcements

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science